Search results for "Colore"

showing 10 items of 1250 documents

Impact of Oat-Based Products on Human Gastrointestinal Tract

2015

Abstract Oat is rich in valuable nutrients. In comparison to other cereals, oat contains more total proteins, carbohydrate, fat, non-starch fibre, as well as unique antioxidants (one of them - avenanthramides), vitamins, and minerals. One of the most often studied components of oats is β-glucan - a type of soluble dietary fibre located throughout the starch endosperm, but with highest concentration in the bran. Many studies have shown the beneficial health effects of oat β-glucan as a soluble dietary fibre. Until now, most of the studies on this nutrient have been conducted in the cardiovascular and diabetology field. This article aimed to review the literature on studies that investigated …

irritable bowel syndromemedicine.medical_specialtyMultidisciplinaryBranColorectal canceravena sativaScienceQHuman gastrointestinal tractfood and beveragesgastrointestinal microfloracolorectal cancermedicine.diseaseInflammatory bowel diseaseUlcerative colitisGastroenterologymedicine.anatomical_structureNutrientinflammatory bowel diseaseInternal medicinemedicineIn patientIrritable bowel syndromeProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
researchProduct

The prognostic role of tumor budding and tumor-stroma ratio in pulmonary metastasis of colorectal carcinoma

2023

Objective To evaluate the prognostic value of tumor budding and tumor-stroma ratio (TSR) in resected pulmonary metastases of colorectal carcinoma (CRC). Methods In total, 106 pulmonary metastasectomies were performed to 74 patients in two study hospitals during 2000–2020. All relevant clinical data were retrospectively collected. Tumor budding based on the International Tumor Budding Consensus Conference recommendations and TSR in the first resected pulmonary metastases and primary tumors were evaluated from diagnostic hematoxylin-eosin-stained histopathological slides. Results 60 patients (85.7%) had low tumor budding (≤5 buds/field) and 10 patients (14.3%) had high tumor budding (>5 buds/…

kasvaimetcolorectal cancerennusteetGeneral Medicinetumor buddingkarsinoomatetäpesäkkeetOncologytumor-stroma ratioSurgerypulmonary metastasessyöpätauditkeuhkotpaksusuolisyöpä
researchProduct

Postoperatīvas aknu mazspējas prognostisko faktoru vērtēšana pēc aknu rezekcijām pie kolorektālā vēža metastāzēm

2016

Ievads. Kolorektālais vēzis ir agresīvs onkoloģisks process, pusei no pacientiem ar kolorektālo vēzi atklāj arī metastātisko slimību, un tā kā aknas ir pirmais orgāns uz metastāžu izplātīšanas ceļa, biežāk novēro kolorektālā vēža metastazēšanas aknās. Joprojām, aknu metastāžu ārstēšanas „zeltā” standarts ir aknu rezekcijas, pēc kā var attīstīties, tā saucama, postoperatīva aknu mazspēja, kas bieži asociējas ar postopertīvas aknu mazspējas prognostīskiem faktoriem. Pētījuma mērķis. Noteikt postoperatīvas aknu mazspējas prognostiskus faktorus, kam ir lielāka aknu mazspējas ietekme. Materiāli un metodes. Retrospektīvs pētījums tika veikts Latvijas Onkoloģijas centrā. Pētījuma tika iekļauti 88 …

kolorektālais vēzisaknu rezekcijaspostoperatīva aknu mazspējahepatic resectionscolorectal cancerMedicīna
researchProduct

Saslimstība ar kuņģa un kolorektālo vēzi Latvijā un vēža slimnieku uzskaites sistēmas ticamības un kvalitātes analīze

2013

Promocijas darba anotācija Saslimstība ar kuņģa un kolorektālo vēzi Latvijā un vēža slimnieku uzskaites sistēmas ticamības un kvalitātes analīze Promocijas darbā ir veikta saslimstības ar kuņģa un kolorektālo vēzi Latvijā analīze un vēža slimnieku uzskaites sistēmas kvalitātes noteikšana. Pētījumā tika analizēta 1980.-2010.gadā reģistrā iesniegtā informācija par pacientiem, kuri slimo ar onkoloģiskām slimībām, iesniegto datu apjoms un to kvalitāte, datu atbilstība statistisko aprēķinu un epidemioloģisko pētījumu veikšanai, un notikušo pārmaiņu ietekme uz pacientu uzskaiti. Iegūtie epidemioloģiskie rādītāji tika salīdzināti ar starptautiskās publikācijās un datubāzēs pieejamo informāciju. Pa…

kolorektālais vēziscancer registry - data qualitygastric cancerkuņģa vēzisHealth carecolorectal cancervēža reģistrs - datu kvalitāteMedicīna un farmācijaVeselības aprūpeMedicīna
researchProduct

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch r…

2022

Abstract Objective To compare colorectal cancer (CRC) incidences in carriers of pathogenic variants of the MMR genes in the PLSD and IMRC cohorts, of which only the former included mandatory colonoscopy surveillance for all participants. Methods CRC incidences were calculated in an intervention group comprising a cohort of confirmed carriers of pathogenic or likely pathogenic variants in mismatch repair genes (path_MMR) followed prospectively by the Prospective Lynch Syndrome Database (PLSD). All had colonoscopy surveillance, with polypectomy when polyps were identified. Comparison was made with a retrospective cohort reported by the International Mismatch Repair Consortium (IMRC). This com…

koloskopiaEuropean Hereditary Tumour Group (EHTG) and the International Mismatch Repair Consortium (IMRC)Epidemiology3122 Cancersehkäisycolorectal cancerPenetrancesegregaatioläpäisevyyssuolistosyövätGUIDELINESover-diagnosisSDG 3 - Good Health and Well-beingpreventionTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]1112 Oncology and CarcinogenesisOncology & CarcinogenesispenetranceLynchin oireyhtymäEpidemiologiaSegregation analysisOver-diagnosiGenetics (clinical)segregation analysisScience & TechnologyIncidencePreventionColonoscòpiaGERMLINE MUTATIONSColonoscopyprospectiveCARRIERSColorectal cancer3142 Public health care science environmental and occupational healthProspectiveLynch syndromeOncologyLynch SyndromeOver-diagnosisincidence/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingCLINICAL MANAGEMENTilmaantuvuusLife Sciences & Biomedicine
researchProduct

Survival by colon cancer stage and screening interval in Lynch syndrome:a prospective Lynch syndrome database report

2019

Abstract Background We previously reported that in pathogenic mismatch repair (path_MMR) variant carriers, the incidence of colorectal cancer (CRC) was not reduced when colonoscopy was undertaken more frequently than once every 3 years, and that CRC stage and interval since last colonoscopy were not correlated. Methods The Prospective Lynch Syndrome Database (PLSD) that records outcomes of surveillance was examined to determine survival after colon cancer in relation to the time since previous colonoscopy and pathological stage. Only path_MMR variants scored by the InSiGHT variant database as class 4 or 5 (clinically actionable) were included in the analysis. Results Ninety-nine path_MMR ca…

koloskopialcsh:QH426-470SurvivalColorectal cancer3122 CancersCancer stageColonoscopycomputer.software_genreMLH1lcsh:RC254-28203 medical and health sciences0302 clinical medicineCàncer colorectalmedicineColon cancer.Stage (cooking)Lynchin oireyhtymäGenetics (clinical)paksusuolisyöpäSurveillanceDatabasemedicine.diagnostic_testbusiness.industryResearchCancerColonoscòpiaColonoscopymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensColorectal cancerLynch syndromedigestive system diseases3. Good healthColon cancerMSH6lcsh:GeneticsLynch syndromeOncologyMSH2030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinesshenkiinjääminencomputer
researchProduct

Role of Type I and II Interferons in Colorectal Cancer and Melanoma

2017

Cancer can be considered an aberrant organ with a hierarchical composition of different cell populations. The tumor microenvironment, including the immune cells and related cytokines, is crucial during all the steps of tumor development. In particular, type I and II interferons are involved in a plethora of mechanisms that regulate immune responses in cancer, thus balancing immune escape versus immune surveillance. Interferons are involved in both the direct and indirect regulation of cancer cell proliferation and metastatic potential. The mutational background of genes involved in interferons signaling could serve as a prognostic biomarker and a powerful tool to screen cancer patients elig…

lcsh:Immunologic diseases. Allergy0301 basic medicineColorectal cancerCellImmunologyContext (language use)ReviewBiology03 medical and health sciencesImmune systemInterferonmedicineAnti-cancer therapy; Cancer; Cancer progression; Colon; Interferon; Melanoma; Tumor immunology; Immunology and Allergy; ImmunologymelanomaImmunology and Allergycancertumor immunologyTumor microenvironmentcolonMelanomaCancerinterferonmedicine.diseasecancer progression030104 developmental biologymedicine.anatomical_structureImmunologyCancer researchlcsh:RC581-607anti-cancer therapymedicine.drugFrontiers in Immunology
researchProduct

Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer

2017

One of the most fascinating aspects of the immune system is its dynamism, meant as the ability to change and readapt according to the organism needs. Following an insult, we assist to the spontaneous organization of different immune cells which cooperate, locally and at distance, to build up an appropriate response. Throughout tumor progression, adaptations within the systemic tumor environment, or macroenvironment, result in the promotion of tumor growth, tumor invasion and metastasis to distal organs, but also to dramatic changes in the activity and composition of the immune system. In this work, we show the changes of the B-cell arm of the immune system following tumor progression in the…

lcsh:Immunologic diseases. Allergy0301 basic medicineColorectal cancerImmunologySpleenintestinal cancerBiologylcsh:RC254-282Metastasis03 medical and health sciencesImmune systemPeritoneummedicineImmunology and Allergyapcmin/+ miceApcMin/+mice; B lymphocytes; IgA; IL-10; intestinal cancer; Immunology and Allergy; Immunology; OncologyB lymphocyteApcMin/+micelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasePhenotypeInterleukin 10030104 developmental biologymedicine.anatomical_structureOncologyTumor progressionIL-10Immunologyb lymphocyteslcsh:RC581-607IgAOncoImmunology
researchProduct

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study

2017

IF 7.719; International audience; Introduction: Some studies have suggested that baseline tumor-infiltrating-lymphocytes (TILs), such as CD8+ and FoxP3+ T-cells, may be associated with a better prognosis in colorectal cancer. We sought to investigate modulation of the immune response by preoperative radiotherapy (preopRT) and its impact on survival in locally advanced rectal cancer (LARC). Materials & Methods: We analyzed data for 237 patients with LARC who received RT. Density of TILS (CD8+ and FoxP3+) in intraepithelial (iTILs) and stromal compartments (sTILs) were evaluated from surgery pathological specimens and biopsies performed at baseline. The primary endpoint was to assess the impa…

lcsh:Immunologic diseases. Allergy0301 basic medicineOncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentImmunology[SDV.CAN]Life Sciences [q-bio]/Cancerchemical and pharmacologic phenomenalcsh:RC254-282radiation therapy[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointImmunology and Allergyrectal cancertranslational studyOriginal ResearchUnivariate analysisbusiness.industryTumor-infiltrating lymphocytesDose fractionationFOXP3hemic and immune systemslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.disease3. Good healthRadiation therapy030104 developmental biologyOncology030220 oncology & carcinogenesistumor-infiltrating lymphocyteslcsh:RC581-607businessAdjuvant
researchProduct

EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells.

2015

KRAS mutational status is considered a negative predictive marker of the response to anti-EGFR therapies in colorectal cancer (CRC) patients. However, conflicting data exist regarding the variable response to EGFR-targeted therapy. The effects of oncogenic KRAS on downstream targets were studied in cell lines with different KRAS mutations. Cells harboring a single KRASG13D allele showed the most tumorigenic profile, with constitutive activation of the downstream pathway, rendering them EGF-unresponsive. Conversely, KRASA146T cells showed a full EGF-response in terms of signal transduction pathways, cell proliferation, migration or adhesion. Moreover, the global acetylome of CRC cells was al…

lcsh:MedicineBiologymedicine.disease_causeHeterogeneous-Nuclear RibonucleoproteinsProto-Oncogene Proteins p21(ras)Epidermal growth factorCell Line TumormedicineHumansCell adhesionlcsh:ScienceMutationMultidisciplinaryEpidermal Growth FactorCell growthlcsh:RAcetylationCell migrationHCT116 CellsGene Expression Regulation NeoplasticDrug Resistance NeoplasmAcetylationMutationCancer researchlcsh:QKRASSignal transductionColorectal NeoplasmsResearch ArticleSignal TransductionPLoS ONE
researchProduct